Plexāā Secures $4.5 Million to Launch Innovative Breast Surgery Device in the U.S.
Plexāā's recent funding extension underscores the potential of its BLOOM⁴³ device to revolutionize breast surgery outcomes by reducing complications through Supraphysiological Preconditioning.
Plexāā, a MedTech startup, has successfully closed a $4.5 million funding extension to support the U.S. launch of its BLOOM⁴³ device, aimed at reducing complications in breast surgeries. The device, which utilizes Supraphysiological Preconditioning to improve surgical outcomes, has shown promise in reducing the high complication rates associated with breast surgeries, including infections and the need for additional procedures.
The funding round was led by TCP Health Ventures, with contributions from existing and new investors, including a significant grant from the National Institute for Health and Care Research. This financial backing not only facilitates the commercial launch of BLOOM⁴³ in the U.S. but also supports the development of future innovations in surgical care.
Dr. Saahil Mehta, founder and CEO of Plexāā, expressed gratitude towards the team and investors for their support, highlighting the confidence in their technology and its potential to benefit a wider patient population. The company's approach to prehabilitation and preconditioning represents a significant advancement in surgical care, with implications for improving patient experiences and outcomes across various surgical specialties.
Investors like Tatum Getty of THENA Capital have recognized Plexāā's potential to address critical challenges in the surgical pathway, emphasizing the importance of reducing post-operative complications. The company's ambition to expand globally and its focus on women's health and adjacent categories underscore the broader impact of its technology on healthcare.
With plans to collaborate with clinicians and partners worldwide, Plexāā is poised to make prehabilitation and preconditioning a standard of care in surgery, offering transformative solutions to unmet needs in surgical care.